## A Spreading Health Crisis in the Democratic Republic of Congo The Democratic Republic of Congo (DRC) is currently battling a significant and expanding outbreak of Bundibugyo virus disease (BVD), a severe and often fatal form of Ebola. The latest health reports reveal a worrying escalation in both the number of confirmed cases and the geographical spread of the virus within the country. This ongoing situation has been recognized as a Public Health Emergency of International Concern (PHEIC), signaling the need for urgent and coordinated international action to contain its devastating impact. As of late August 2026, the outbreak has spread to 60 health zones across six of the DRC's 26 provinces, a substantial increase from 54 health zones just weeks prior. The affected provinces now include Bas-Uélé, Haut-Uélé, Ituri, North Kivu, South Kivu, and Tshopo. Overall, the DRC has recorded 5,794 confirmed cases, leading to 2,786 deaths, which translates to a stark case fatality rate of 48.1%. These figures highlight the severe nature of the disease and the persistent difficulties in identifying cases early, providing timely and effective medical care, and stopping the virus from spreading further within communities and healthcare facilities. ## Understanding Bundibugyo Virus Disease (BVD) Bundibugyo virus disease is a severe illness belonging to the family of Ebola viruses, caused specifically by the Bundibugyo virus, one of the *Orthoebolavirus* species. This particular virus is known to originate in animals, making it a zoonotic disease, with fruit bats suspected as its natural carriers. Humans typically contract BVD through close contact with the blood or other bodily fluids of infected wild animals, such as bats or non-human primates. Once a human is infected, the virus can then spread from person to person through direct contact with blood, secretions, organs, or other body fluids of infected individuals, or through contact with contaminated surfaces and materials. The incubation period for BVD, which is the time between exposure to the virus and the onset of symptoms, can range from two to 21 days. Crucially, individuals are not infectious until they start showing symptoms. Early symptoms are often non-specific and can resemble common illnesses like malaria or the flu, including fever, fatigue, muscle pain, headache, and a sore throat. This similarity makes early diagnosis challenging and can lead to delays in detection. As the disease progresses, patients may experience severe gastrointestinal issues, organ dysfunction, and, in some cases, internal and external bleeding. Historical outbreaks of BVD in Uganda (2007) and the DRC (2012) reported case fatality rates of 30% and 50% respectively, underscoring the lethal potential of this virus. ## The Unfolding Situation on the Ground The current outbreak represents the second documented Bundibugyo virus disease epidemic in the DRC and is the largest Ebola outbreak ever recorded in the country, regardless of the specific Ebola virus species. The virus has shown persistent transmission and considerable expansion. Ituri province remains the epicenter, reporting the highest number of cases since the outbreak began, followed by North Kivu, which has recorded a particularly high case fatality rate of 68%—a figure currently under investigation. The expansion into new health zones, such as Ganga and Viadana in Bas-Uélé province, and Biena, Manguredjipa, and Mutwanga in North Kivu, demonstrates the ongoing challenge of containing the virus's reach. Responding to the outbreak’s rapid spread, the number of individuals requiring contact monitoring has also increased dramatically. As of late August, health teams were actively following up on a significant number of contacts to identify new cases quickly and break chains of transmission. The large scale of contact tracing efforts reflects the extensive potential for exposure within affected communities and the critical need for comprehensive surveillance. ## A Backdrop of Humanitarian Crisis The fight against BVD in the DRC is occurring within an extremely complex and challenging environment. The country is grappling with ongoing conflict, armed violence, and widespread insecurity, which have led to massive population displacement. More than 26 million people face acute food insecurity, and Ituri Province alone hosts an estimated one million internally displaced people. These severe humanitarian conditions significantly hinder the public health response. Insecurity restricts access for response teams, making surveillance, case investigation, and contact follow-up incredibly difficult. Overcrowding, limited access to clean water, sanitation, and hygiene services, particularly in mining communities, informal settlements, and displacement camps, further complicate efforts to detect cases early, prevent infections, and provide appropriate care. These factors create an environment where the virus can spread more easily and response measures are harder to implement consistently. ## Global Vigilance and Regional Risks While the primary focus of the outbreak is within the DRC, the risk of international spread remains a significant concern. Although countries like Uganda and France have successfully completed their 42-day enhanced monitoring periods—a standard measure to ensure no further transmission—the continuous movement of people across borders, particularly through informal routes, presents an ongoing risk. The World Health Organization (WHO) has assessed the risk of spread to neighboring countries sharing land borders with the DRC, such as Uganda, the Central African Republic, and South Sudan, as high. This is due to sustained population mobility linked to trade and mining activities, coupled with varying levels of preparedness and health system capacities in these regions. For countries like the Central African Republic and South Sudan, existing humanitarian needs, displacement, and insecurity further amplify these risks. Therefore, robust cross-border collaboration and sustained surveillance measures are essential to prevent further regional spread and ensure an effective public health response. ## Mounting a Comprehensive Public Health Response The health authorities in the DRC, in close collaboration with the WHO and numerous international partners, are implementing extensive public health measures to combat the outbreak. These efforts span multiple critical areas: enhancing disease surveillance to detect cases swiftly, expanding laboratory testing capabilities for rapid confirmation, strengthening infection prevention and control (IPC) measures in healthcare settings, and providing optimal clinical care to patients. Community engagement is also a cornerstone of the response, fostering trust and cooperation to encourage safe practices, including safe burial rituals and reporting symptoms early. Furthermore, the response includes vital logistical support, research initiatives, and sustained efforts to mobilize resources and address funding gaps to ensure ongoing operations in affected and at-risk areas. A substantial scale-up across all these response pillars is underway, aiming to get ahead of the outbreak's rapid progression. ## Hope on the Horizon: Vaccine and Treatment Trials One of the critical developments in the response is the initiation of vaccine and treatment trials. On August 27, vaccination of healthcare workers using the Ervebo vaccine began in some areas of the DRC, including Kisangani in Tshopo province. While Ervebo is a proven and licensed vaccine highly effective against Ebola caused by the *Zaire ebolavirus* species, its protective efficacy against the *Bundibugyo virus* in humans is not yet known. Recognizing this, a randomized clinical trial of Ervebo is being conducted alongside its wider use, aiming to gather crucial evidence to inform its future application against BVD. In parallel, a clinical trial known as the PARTNERS trial is actively seeking effective treatments for BVD. This trial commenced enrollment on July 2, 2026, and is currently operating in three clinical management facilities in Ituri province, having already enrolled over 250 confirmed cases. The outcomes of both the vaccine and treatment trials are eagerly awaited, as they hold the promise of significantly improving the tools available to combat this severe disease. ## International Health Regulations and WHO Recommendations The re-declaration of the Bundibugyo outbreak as a Public Health Emergency of International Concern (PHEIC) by the WHO's Emergency Committee on August 18 underscores the serious nature of this crisis and its potential international implications. A PHEIC signifies an extraordinary event that poses a public health risk to other states through international spread and potentially requires a coordinated international response. Despite the severity, the WHO continues to advise against any restrictions on travel to or trade with affected countries, emphasizing that such measures are often ineffective and can impede response efforts. Instead, the focus remains on robust public health interventions, advocating for coordinated outbreak control, strengthened cross-border collaboration, and consistent surveillance and preparedness. Rapid identification of cases, prompt testing, and optimized supportive care are crucial strategies, not only for reducing mortality but also for building community trust and acceptance of health services within the response. ## Looking Ahead: Sustained Commitment is Key The ongoing Bundibugyo virus disease outbreak in the Democratic Republic of Congo represents a complex and evolving public health challenge. Its rapid expansion, high fatality rate, and the compounding factors of conflict, insecurity, and humanitarian crises demand sustained attention and resources. The dedicated efforts of health authorities, supported by international partners, in surveillance, clinical care, community engagement, and critical research into vaccines and treatments, offer hope amidst the adversity. The global health community's continued commitment to collaboration, preparedness, and compassionate response will be vital in overcoming this formidable health crisis and protecting lives both within the DRC and beyond.